Related Experiment Video
Updated: May 28, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Persistent genital arousal disorder: successful treatment with duloxetine and pregabalin in two cases
Susanne Philippsohn1, Tillmann H C Kruger
1Department of Psychiatry, Social Psychiatry, and Psychotherapy, Clinical Psychology, Hannover Medical School, Hannover, Germany. philippsohn.susanne@mh-hannover.de
Introduction:
Persistent genital arousal disorder (PGAD) is a rare condition in women that causes a lot of suffering. The pathophysiology is not well understood and an approach promising effective treatment has not been established so far.
Aim:
This study aims to make colleagues aware of two treatment options, which proved to be successful in one case each and which might be worth further investigation.
Main Outcome Measures:
Subjective distress from unwanted sexual arousal, unwanted orgasms, and pain in the genital area.
Methods:
Treatment of two women--36 and 41 years old--suffering from PGAD with duloxetine and pregabalin, respectively.
Results:
In both women, the treatment proved to be very successful over a long period of time. One of them experienced full remission (duloxetine) and the other one experienced substantial improvement (pregabalin), over a period now lasting for more than a year.
Conclusion:
Pregabalin and duloxetine, in particular, should be further investigated as possible medication for the treatment of PGAD.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antidepressant Drugs: MAOIs and Other Agents
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Sex Linked Disorders
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
